“When my daughter got sick, I took her to a clinic in my neighborhood. They gave her cough syrup for seven days…
-
post Ending a Global Epidemic: Tuberculosis in Children #UnitetoEndTB
-
Global health The U.S. Needs a Lesson in Food Policy from Mexico by Daniel Taber, PhD, MPH
What do you tell people when you’re an invited “expert,” yet in some ways you’re the dumbest person in the room? That…
-
Global health From the archives: A Story of 20,000 Healthy Mothers and Babies by Dr. Nosakhare Orobaton
[Originally published as a PLOS BLOGS Network guest post on December 10, 2013] By Dr. Nosakhare Orobaton To mark Year Three of the…
-
Global health Known Knowns and Unknowns of U.S. Drug Pricing
By Joshua P. Cohen Research Associate Professor, Tufts Center for the Study of Drug Development (Full bio below this post) Media scrutiny…
-
Autism NeuroTribes, Steve Silberman on a haunting history and new hope for autistic people
[Congratulations to Steve Silberman, just awarded the 2015 Samuel Johnson Prize, UK’s top nonfiction award for NeuroTribes. This interview with Silberman by Emily…
-
ethics Talking drug prices, Pt 6: Openness vs. secrecy in drug development By Mat Todd
Welcome to the sixth and final post in a PLOS BLOGS series, Talking about Drug Prices & Access to Medicines. To borrow a phrase from one of…
-
Global health Talking Drug Prices, Pt 5: Double-billed… By Manica Balasegaram, MSF
Welcome to part five in a PLOS BLOGS six-part series, Talking about Drug Prices & Access to Medicines. To borrow a phrase from one of our…
-
post Talking Drug Prices, Pt 4 Drug pricing is out of control, what should be done? By James Love
Welcome to part four in a PLOS BLOGS six-part series, Talking about Drug Prices & Access to Medicines. To borrow a phrase from one of our…
-
ethics Talking Drug Prices, Pt. 3 If you play with scorpions, don’t be surprised when you get stung by Atif Kukaswadia
Welcome to the third in a PLOS BLOGS six-part series, Talking about Drug Prices & Access to Medicines. To borrow a phrase from one of…
-
post Talking Drug Prices Pt 2: This Blog Post Will Cost You by Jessica Wapner
Welcome to the second in a PLOS BLOGS six-part series, Talking about Drug Prices & Access to Medicines. To borrow a phrase from one…
-
post Talking about Drug Prices & Access to Medicines Pt 1: By Els Torreele, Open Society Foundations
Welcome to a PLOS BLOGS six-part series, Talking about Drug Prices & Access to Medicines. To borrow a phrase from one of our bloggers…
-
Open Access Open Access From a Patient Advocate’s Perspective: “Inserting Ourselves into the Science of a Condition”
An OA Week guest post by patient advocate Christy Collins My daughter, Signe, was born with a very rare genetic condition called…